Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins believes it is a global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies.
In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 47,000 staff across a network of more than 900 independent companies in over 50 countries and operating more than 800 laboratories. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
In 2026, Eurofins generated total revenues of EUR € 4.56 billion, and has been among the best performing stocks in Europe over the past 20 years.
The President of Eurofins BioPharma Product Testing (BPT) Columbia is responsible for leading one of the largest and most successful BioPharma testing operations within the Eurofins network. This executive serves as the chief business leader for the site, with full accountability for growth, profitability, operational excellence, customer satisfaction, quality, compliance, employee engagement, and long-term strategic development.
The ideal candidate is a growth-oriented life sciences executive who combines strong commercial acumen, operational excellence, financial discipline, technological innovation, and people-centered leadership. This leader will guide the next phase of expansion while preserving the entrepreneurial culture, high employee engagement, and operational excellence that have fueled Columbia's growth.
The successful candidate will embody the Eurofins Mission and Values by contributing to a safer and healthier world through innovative, high-quality laboratory services while creating opportunities for employees and generating sustainable shareholder value. Eurofins' core values include Customer Focus, Quality, Competence & Team Spirit, and Integrity.
Scope of Responsibility
Business Scale
Service Portfolio
Responsible for a comprehensive range of pharmaceutical development and GMP testing services including:
Strategic Responsibilities
Critical Success Factors
1. Commercial Growth and Customer Diversification
The next President must be a commercially focused business leader capable of partnering effectively with the North American commercial team to expand the customer portfolio and reduce concentration risk.
Key Objectives
Desired Experience
2. Operational Excellence, Automation, and AI
The future success of Columbia will require significant advancements in automation, digital transformation, and global service delivery models.
Key Objectives
Desired Experience
3. Capacity Expansion and Infrastructure Development
The next President will lead the site's next major phase of physical growth.
Key Objectives
Desired Experience
4. Culture and Talent Leadership
One of Columbia's greatest strengths is its culture. The successful candidate must preserve and enhance this competitive advantage while continuing to create opportunities for employees.
Key Objectives
Leadership Expectations
The President should consistently model:
while reinforcing Eurofins' mission of creating opportunities for employees, providing exceptional service to customers, and generating sustainable shareholder value.
Leadership Characteristics
The ideal candidate will be:
Strategic
Able to develop and execute a long-term vision for growth while managing near-term priorities.
Commercially Driven
Views customer diversification and business development as critical responsibilities.
Financially Disciplined
Understands how to balance growth, investment, productivity, and profitability.
Technology Forward
Embraces AI, automation, digital transformation, and innovation as competitive differentiators.
Operationally Excellent
Capable of driving efficiency improvements without compromising quality or culture.
People Focused
Invests in leaders, develops talent, and creates opportunities throughout the organization.
Culture Builder
Protects the entrepreneurial culture that has driven Columbia's success while preparing the organization for its next chapter of growth.
Preferred Candidate Background
The strongest candidates will likely possess experience in:
Demonstrated experience should include:
What Success Looks Like in 3–5 Years
The successful President will have:
In a fast growing group, successful leaders are frequently being offered increased areas of responsibility (subject to geographic mobility).
Eurofins offers international opportunities to strong performers.
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.
